In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Lars Lund
Speaker
Lars Lund
Lars Lund Lars Lund

Karolinska University Hospital, Stockholm (Sweden)

Specialities : Chronic Heart Failure , Acute Heart Failure, Research Methodology

Lars Lund is Professor of Cardiology at Karolinska Institutet and University Hospital in Stockholm. His research focuses on heart failure: implementation of existing therapy in HFrEF and development of novel therapy in HFpEF

37 presentations from this speaker

SPIRRIT-HFpEF: spironolactone versus usual care in HFpEF.

Event : ESC Congress 2020

  • Session : Pragmatic Cardiovascular Trials - A New Approach to Generating Evidence
  • Speaker : L Lund (Stockholm,SE)

Big Data as driver for learning healthcare system.

Event : ESC Congress 2019

  • Session : How Big Data will impact cardiology: a physician’s guide
  • Speaker : L Lund (Stockholm,SE)

Clinical trajectories and risk assessment.

Event : Heart Failure 2019

  • Session : HFmEF: clinical and therapeutic dilemmas
  • Speaker : L Lund (Stockholm,SE)

Experts debate - Challenges faced in diagnosing and managing HFpEF.

Event : Heart Failure 2019

  • Session : Challenges faced in diagnosing and managing HFpEF
  • Speaker : CS Lam (Singapore,SG), JJV McMurray (Glasgow,GB), B Pieske (Berlin,DE), L Lund (Stockholm,SE), A Voors (Groningen,NL)
  • Organised by Medscape Education, supported with an educational grant from Novartis

Fluid removal therapies.

Event : Heart Failure 2019

  • Session : Advances in therapeutic interventions in acute heart failure
  • Speaker : L Lund (Stockholm,SE)

From past to the future: Heart Failure Registry III.

Event : Heart Failure 2019

  • Session : Heart failure epidemiology and registries
  • Speaker : L Lund (Stockholm,SE)

HFpEF: The patients journey

Event : Heart Failure 2019

  • Session : Meet the experts on getting to grips with HFpEF
  • Speaker : L Lund (Stockholm,SE)
  • Organised by Medscape Education, supported with an educational grant from Novartis

How well do you know HFpEF? Meet the experts

Event : ESC Congress 2019

  • Session : How well do you know HFpEF? Meet the experts
  • Speaker : L Lund (Stockholm,SE), JJV McMurray (Glasgow,GB), S Solomon (Boston,US)
  • Organised by Medscape Education, supported with an independent grant from Novartis Pharma AG

Mineralocorticoid receptor antagonist.

Event : Heart Failure 2019

  • Session : Emerging treatment options in HFpEF
  • Speaker : L Lund (Stockholm,SE)

Questions and answers - Management of hyperkalaemia in patients with heart failure – A multidisciplinary approach.

Event : Heart Failure 2019

  • Session : Management of hyperkalaemia in patients with heart failure – A multidisciplinary approach
  • Speaker : L Lund (Stockholm,SE)
  • Organised by MedEd Global Solutions & University of Lorraine, supported with an educational grant from Vifor Pharma

The challenges of managing HFpEF today

Event : ESC Congress 2019

  • Session : The heart failure challenge: how well do you know HFpEF?
  • Speaker : L Lund (Stockholm,SE)
  • Organised by Medscape Education, supported with an independent grant from Novartis Pharma AG

Welcome and introduction - Management of hyperkalaemia in patients with heart failure – A multidisciplinary approach.

Event : Heart Failure 2019

  • Session : Management of hyperkalaemia in patients with heart failure – A multidisciplinary approach
  • Speaker : L Lund (Stockholm,SE)
  • Organised by MedEd Global Solutions & University of Lorraine, supported with an educational grant from Vifor Pharma

Case study on comparative prevalence of heart failure across 4 European countries using a Big Data approach .

Event : ESC Congress 2018

  • Session : BigData@Heart
  • Speaker : L Lund (Stockholm,SE), S Koudstaal (Rotterdam,NL)

Conclusion - Heart Failure (HF) case debates with the experts.

Event : Heart Failure 2018

  • Session : Heart failure case debates with the experts
  • Speaker : L Lund (Stockholm,SE), S Anker (Berlin,DE)
  • Organised by Medscape Education, supported with an educational grant by Novartis

Devices and interventions

Event : Heart Failure 2018

  • Session : Heart Failure 2018 Highlights
  • Speaker : L Lund (Stockholm,SE)

Epidemiology - Global view

Event : Heart Failure 2018

  • Session : Heart failure as a major local and global challenge in the 21st century
  • Speaker : L Lund (Stockholm,SE)

HFmrEF is similar to HFrEF - PRO

Event : Heart Failure 2018

  • Session : GRAND DEBATE II - Controversies in the definition and management of heart failure
  • Speaker : L Lund (Stockholm,SE)

Introduction - Heart Failure (HF) case debates with the experts.

Event : Heart Failure 2018

  • Session : Heart failure case debates with the experts
  • Speaker : L Lund (Stockholm,SE)
  • Organised by Medscape Education, supported with an educational grant by Novartis

Question period.

Event : Heart Failure 2018

  • Session : Heart failure case debates with the experts
  • Speaker : L Lund (Stockholm,SE)
  • Organised by Medscape Education, supported with an educational grant by Novartis

When should a patient be referred for advanced heart failure therapies?

Event : Heart Failure 2018

  • Session : Advanced heart failure - The new HFA consensus
  • Speaker : L Lund (Stockholm,SE)

Chair’s introduction - Lighting the way: a new path to manage hyperkalaemia.

Event : ESC Congress 2017

  • Session : Lighting the way: a new path to manage hyperkalaemia (EBAC Accredited)
  • Speaker : L Lund (Stockholm,SE)
  • Sponsored by AstraZeneca

Contemporary outcomes after heart transplantation and left ventricular assist systems.

Event : Heart Failure 2017

  • Session : 50th anniversary of heart transplantation
  • Speaker : L Lund (Stockholm,SE)

Heart failure with mid ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire EF spectrum.

Event : Heart Failure 2017

  • Session : Late Breaking Trials II: Focus on chronic heart failure
  • Speaker : L Lund (Stockholm,SE)

Indications: not too early, not too late.

Event : Heart Failure 2017

  • Session : Challenging heart team decisions in patients with ventricular assist systems
  • Speaker : L Lund (Stockholm,SE)

Panel Q&A - Discussion - Lighting the way: a new path to manage hyperkalaemia.

Event : ESC Congress 2017

  • Session : Lighting the way: a new path to manage hyperkalaemia (EBAC Accredited)
  • Speaker : L Lund (Stockholm,SE), GMC Rosano (London,GB), M Kosiborod (Kansas,US)
  • Sponsored by AstraZeneca

RAASi therapy benefit and challenges in cardio-renal patients.

Event : Heart Failure 2017

  • Session : Enabling and optimizing Renin-Angiotensin-Aldosterone-System inhibitors (RAASi) therapy in cardio-renal patients by controlling potassium levels
  • Speaker : L Lund (Stockholm,SE)
  • Sponsored by Vifor Pharma / Vifor Fresenius Medical Care Renal Pharma

Renin-angiotensin inhibitors in patients with concomitant renal dysfunction.

Event : Heart Failure 2017

  • Session : Dilemmas in the dosing of HFrEF drugs
  • Speaker : L Lund (Stockholm,SE)

Short-term mechanical support: how, for whom and when

Event : ESC Congress 2017

  • Session : Advanced heart failure: when drugs alone are not enough
  • Speaker : L Lund (Stockholm,SE)

What do the Guidelines say about devices?

Event : Heart Failure 2017

  • Session : Guidelines in Daily Practice V: arrhythmias and devices
  • Speaker : L Lund (Stockholm,SE)

Doing fine after LVAD: still need a transplant?

Event : Heart Failure 2016

  • Session : Devices at crossroads
  • Speaker : L Lund (Stockholm,SE)

Pharmacological management.

Event : Heart Failure 2016

  • Session : Cardiogenic shock: how can we improve prognosis?
  • Speaker : L Lund (Stockholm,SE)

Association between beta blockers and outcomes in patients with heart failure and preserved ejection fraction

Event : ESC Congress 2014

  • Session : Registry Hot Line: Valves and heart failure
  • Speaker : L Lund (Stockholm,SE)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are